We provide contract development and manufacturing services that enable pharma and biotech companies to deliver medicines to patients in need. From the building blocks of life to the final drug product, our solutions are created to simplify your outsourcing experience and provide a reliable outcome when you expect it. Our extensive track record includes commercialization of pioneering therapies and manufacturing of a wide variety of drugs. Together, we can bring the next medicine to life.
ACEA Biosciences pioneers the development and commercialization of cutting edge cell analysis instruments. Employing noninvasive impedance microelectrodes in automated high-throughput plate formats, our xCELLigence®Real-Time Cell Analysis instruments enable label-free, real-time monitoring of cell proliferation, cell size/morphology, cell-substrate attachment quality, and cell invasion/migration. Salient applications include cancer drug discovery and immunotherapy cell killing assays. ACEA is also helping to revolutionize the field of flow cytometry by producing high performance, customizable benchtop cytometers at accessible price points. Our NovoCyte™ flow cytometers include up to 13 fluorescence detection channels with 3 lasers, direct volumetric-based cell counting, and a versatile high throughput walkaway autosampler.